Results 131 to 140 of about 47,347 (229)

Lysophosphatidic Acid

British Journal of Pharmacology, 2009
openaire   +3 more sources

AGPAT3 Regulates Immune Microenvironment in Osteosarcoma via Lysophosphatidic Acid Metabolism. [PDF]

Oncol Res
Su S, Zeng Y, Chen J, Dong X.
europepmc   +1 more source

Lysophosphatidic acid: a promising biomarker for diagnosing sepsis and predicting in-hospital mortality. [PDF]

Front Immunol
Li X, Li T, Xuan P, Wang H, Yang J.
europepmc   +1 more source

Autotaxin and Lysophosphatidic Acid Circulating Levels Correlate with Body Mass Index in Obese Subjects with MASLD. [PDF]

Int J Mol Sci
Tatoli R, Bonfrate L, Bonfiglio C, Pesole PL, Stabile D, Donghia R, De Pergola G, Giannelli G.   +7 more
europepmc   +1 more source

Chemiluminescent Biosensor Utilizing Magnetic Particles for the Detection of Ovarian Cancer Biomarker Lysophosphatidic Acid. [PDF]

Biosensors (Basel)
Lotay N, Thompson M.
europepmc   +1 more source

Demyelination-related pain: role of lysophosphatidic acid in satellite glial cell-neuron crosstalk. [PDF]

J Transl Med
Wang Y, Sun Q, Hanani M, Qu J, Guo X, Yang W, Shao T, Zheng S, Qiao S, Jia Y, Huang Y, Yang Y, Zhu H, Dong X, Zhou FQ, Guan Y, Song X, Chen Z.   +17 more
europepmc   +1 more source

Gintonin as a Lysophosphatidic Acid-Enriched GPCR Ligand System: Molecular Architecture and Receptor Pharmacology in <i>Panax ginseng</i>. [PDF]

Biomolecules
Kim KH, Yoo BC.
europepmc   +1 more source

Lysophosphatidic acid-mediated NF-κB activation promotes FOXC2 expression essential for lymphatic valve development. [PDF]

J Clin Invest
Yasuda D, Sato N, Yanagida K, Hashidate-Yoshida T, Shiiya T, Shindou H, Taira A, Ebihara T, Shimizu T, Hirashima M, Mizuno S, Takahashi S, Ishii S.   +12 more
europepmc   +1 more source

Oxypeucedanin attenuates neuropathic pain in male mice via inhibiting lysophosphatidic acid receptor signaling. [PDF]

iScience
Li J, Tang W, Wang L, Gu Y, You W, Yang W, Huang Y, Yu X, Zhu R, Xu Y, Li J, Zhu Q.   +11 more
europepmc   +1 more source

Enhancement of malignant potency through lysophosphatidic acid (LPA) receptor signaling in pancreatic cancer cells under hypoxic conditions. [PDF]

Cytotechnology
Nagano S, Takai M, Yashiro N, Shimomura N, Tamura M, Kusumoto Y, Yamamoto M, Tsujiuchi T.   +7 more
europepmc   +1 more source